Yang Luo
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 55
- Cancer Treatment and Pharmacology 24
- HER2/EGFR in Cancer Research 21
- Cancer Cells and Metastasis 7
-
- Breast Cancer Treatment Studies 26
- Cancer Genomics and Diagnostics 6
- Co-authors
- Fei Ma (74 shared papers)Pin Zhang (60 shared papers)Ying Fan (58 shared papers)Binghe Xu (46 shared papers)Qiao Li (43 shared papers)Ruigang Cai (42 shared papers)Shanshan Chen (38 shared papers)Jiayu Wang (37 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Frontiers in Oncology (6 papers)International Journal of Cancer (6 papers)The Breast (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Yang Luo
120 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Oncology 714
- Cancer Research 362
- Pulmonary and Respiratory Medicine 279
- Radiology, Nuclear Medicine and Imaging 161
- Genetics 62
Countries citing papers authored by Yang Luo
This map shows the geographic impact of Yang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Luo more than expected).
Fields of papers citing papers by Yang Luo
This network shows the impact of papers produced by Yang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Luo. The network helps show where Yang Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 171 | |
| 2 | 2019 | 85 | |
| 3 | 2021 | 82 | |
| 4 | 2022 | 75 | |
| 5 | 2019 | 62 | |
| 6 | 2016 | 51 | |
| 7 | 2022 | 46 | |
| 8 | 2017 | 42 | |
| 9 | 2021 | 31 | |
| 10 | 2016 | 30 | |
| 11 | 2008 | 30 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 28 | |
| 14 | 2018 | 27 | |
| 15 | 2016 | 27 | |
| 16 | 2014 | 26 | |
| 17 | 2016 | 26 | |
| 18 | 2020 | 23 | |
| 19 | 2015 | 21 | |
| 20 | 2018 | 20 |
About Yang Luo
Yang Luo is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Immunology, having authored 127 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (24 papers), HER2/EGFR in Cancer Research (21 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Cells and Metastasis (7 papers), Cancer Genomics and Diagnostics (6 papers), Breast Lesions and Carcinomas (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Oncology (714 citations), Cancer Research (362 citations), Pulmonary and Respiratory Medicine (279 citations), Radiology, Nuclear Medicine and Imaging (161 citations) and Genetics (62 citations). Yang Luo has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Fei Ma, Pin Zhang, Ying Fan, Binghe Xu, Qiao Li, Ruigang Cai, Shanshan Chen, Jiayu Wang, Qing Li and Peng Yuan. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, International Journal of Cancer, The Breast and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.